JHS Svendgaard Laboratories Ltd

JHS Svendgaard Laboratories Ltd share price inched up 1.15% to Rs 7.95. The Company's net profit witnessed a sharp fall of 130.53% to Rs 1.09 crore, while revenue from operations eased by 7.09% to Rs 30.38 crore in Q2FY26 over Q1FY26. The market capitalization of Personal Care industry group stocks on BSE stood at Rs 3.57 lakh crore, climbing 14.21%. It has slipped by 0.66% over last one week and gained upto 1.30% in last one month while the market capitalization of JHS Svendgaard Laboratories Ltd has significantly gained 17.55% and 1.67% in the same period respectively. Profit before tax (PBT) of JHS Svendgaard Laboratories Ltd stood at Rs 0.06 crore in Q2 FY26, nosediving by 90.48% year-on-year, and tumbling by 102.01% quarter-on-quarter. EBITDA came in at Rs 2 crore, surging by 197.01% YoY and tanking 184.68% sequentially. Total expenses fell by 16.72% to Rs 30.13 crore in Q2FY26 over Q2FY25. During the quarter, cost of materials consumed stood at Rs 18.73 crore, plunging by 23.58% YoY, while employee benefits expense was at Rs 2.87 crore, falling 7.72% YoY. For the TTM ended FY26, revenue from operations soared by 29.94% to Rs 92.0 crore, while net profit jumped 386.21% to Rs 19.74 crore, compared to previous TTM. EBITDA saw a sharp decline of 464% to Rs 6.89 crore, and PBT soared 264.72% to Rs 12.51 crore compared to previous TTM. The company's consolidated net cash flow from operating activities stood at Rs 5.18 crore in FY26, as against Rs 9.18 crore in FY25. JHS Svendgaard Laboratories Ltd nosedived by 32.57% in last one year, underperforming the benchmark BSE Sensex which has softened by 2.56% during the same period.

JHS Svendgaard Laboratories Limited informed the Bombay Stock Exchange Limited and National Stock Exchange of India Limited that it has filed a statement of deviation or variation under Regulation 32 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, for the quarter ended June 30, 2026, regarding the utilization of Rs 29.99 crore raised through a preferential issue on June 4, 2024, with Rs 764.46 crore utilized for setting up a new project in Jammu & Kashmir, Rs 749.50 crore for general corporate purposes, and Rs 962.50 crore infused into JHS Svendgaard Retail Ventures Ltd.

JHS Svendgaard Laboratories Limited will hold a board meeting on Tuesday, August 11, 2026, to consider and approve the un-audited financial results (standalone and consolidated) for the quarter ended June 30, 2026, according to a regulatory filing with the Bombay Stock Exchange Limited and the National Stock Exchange of India Limited. The company’s trading window has been closed since July 1, 2026, and will remain closed for 48 hours following the announcement of the results.

Net Loss of JHS Svendgaard Laboratories reported to Rs 3.57 crore in the quarter ended March 2026 as against net loss of Rs 6.96 crore during the previous quarter ended March 2025. Sales rose 29.92% to Rs 32.70 crore in the quarter ended March 2026 as against Rs 25.17 crore during the previous quarter ended March 2025. For the full year,net loss reported to Rs 1.92 crore in the year ended March 2026 as against net loss of Rs 19.74 crore during the previous year ended March 2025. Sales rose 10.53% to Rs 101.69 crore in the year ended March 2026 as against Rs 92.00 crore during the previous year ended March 2025. ParticularsQuarter EndedYear EndedMar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var. Sales32.7025.17 30 101.6992.00 11 OPM %-4.98-21.33 -2.57-4.36 - PBDT-1.13-4.17 73 5.21-1.70 LP PBT-2.98-6.19 52 -2.29-9.65 76 NP-3.57-6.96 49 -1.92-19.74 90 Powered by Capital Market - Live

JHS Svendgaard Laboratories will hold a meeting of the Board of Directors of the Company on 26 May 2026.

Net profit of JHS Svendgaard Laboratories reported to Rs 0.79 crore in the quarter ended December 2025 as against net loss of Rs 1.84 crore during the previous quarter ended December 2024. Sales rose 2.69% to Rs 23.27 crore in the quarter ended December 2025 as against Rs 22.66 crore during the previous quarter ended December 2024. ParticularsQuarter EndedDec. 2025Dec. 2024% Var. Sales23.2722.66 3 OPM %7.181.10 - PBDT1.980.39 408 PBT0.08-1.58 LP NP0.79-1.84 LP Powered by Capital Market - Live

JHS Svendgaard Laboratories will hold a meeting of the Board of Directors of the Company on 10 February 2026.Powered by Capital Market - Live

Net Loss of JHS Svendgaard Laboratories reported to Rs 0.20 crore in the quarter ended September 2025 as against net loss of Rs 10.32 crore during the previous quarter ended September 2024. Sales rose 13.21% to Rs 22.28 crore in the quarter ended September 2025 as against Rs 19.68 crore during the previous quarter ended September 2024. ParticularsQuarter EndedSep. 2025Sep. 2024% Var. Sales22.2819.68 13 OPM %4.08-4.32 - PBDT1.85-0.09 LP PBT-0.02-2.07 99 NP-0.20-10.32 98 Powered by Capital Market - Live

JHS Svendgaard Laboratories will hold a meeting of the Board of Directors of the Company on 14 November 2025.Powered by Capital Market - Live

JHS Svendgaard Laboratories has revised the meeting of the Board of Directors which was scheduled to be held on 13 November 2025. The meeting will now be held on 14 November 2025.Powered by Capital Market - Live